ACCO Brands Corporation (FRA:A3B)

Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	133.3	74.1	66.4	62.2	41.2	36.6
Cash & Short-Term Investments	133.3	74.1	66.4	62.2	41.2	36.6
Cash Growth	18.28%	11.60%	6.75%	50.97%	12.57%	31.66%
Receivables	348.8	348.9	430.7	384.1	416.1	356
Inventory	313.8	270.4	327.5	395.2	428	305.1
Other Current Assets	40	38.1	30.8	40.8	39.6	30.5
Total Current Assets	835.9	731.5	855.4	882.3	924.9	728.2
Property, Plant & Equipment	226	218.5	261.1	273.9	319.8	330.6
Goodwill	471.8	446.4	590	671.5	802.5	827.4
Other Intangible Assets	719.5	709.6	815.7	847	902.2	977
Long-Term Deferred Tax Assets	100.8	89.3	104.7	99.7	115.9	136.5
Other Long-Term Assets	23.6	33.1	17.9	20.3	26	49
Total Assets	2,378	2,228	2,645	2,795	3,091	3,049
Accounts Payable	172.3	167.3	183.7	239.5	308.2	180.2
Accrued Expenses	101.9	129.3	165.1	148.9	165.8	140.4
Short-Term Debt	19.3	10.5	0.2	10.3	9.4	5.7
Current Portion of Long-Term Debt	19.4	40.8	36.5	49.7	33.6	70.8
Current Portion of Leases	22.9	21.5	20.5	21.2	24.4	22.6
Current Unearned Revenue	2.3	2.4	-	-	-	-
Other Current Liabilities	114.8	118.5	136	119.4	167.2	137.2
Total Current Liabilities	452.9	490.3	542	589	708.6	556.9
Long-Term Debt	944.1	783.3	882.2	936.5	954.1	1,055
Long-Term Leases	68.1	66.9	76.8	75.2	89	76.5
Long-Term Unearned Revenue	0.4	0.5	-	-	-	-
Long-Term Deferred Tax Liabilities	116.3	111.9	125.6	144.1	145.2	170.6
Other Long-Term Liabilities	34.1	52.2	73.6	84.3	107.3	130.3
Total Liabilities	1,740	1,622	1,858	1,985	2,227	2,306
Common Stock	1	1	1	1	1	1
Additional Paid-In Capital	1,906	1,912	1,913	1,897	1,902	1,883
Retained Earnings	-686.4	-687.6	-556	-504.4	-462	-537.3
Treasury Stock	-47.9	-47	-45.1	-43.4	-40.9	-39.9
Comprehensive Income & Other	-535.4	-572.1	-526.3	-540.3	-535.5	-564.2
Shareholders' Equity	637.3	606.1	787	810.1	864.8	742.7
Total Liabilities & Equity	2,378	2,228	2,645	2,795	3,091	3,049
Total Debt	1,074	923	1,016	1,093	1,111	1,230
Net Cash (Debt)	-940.5	-848.9	-949.8	-1,031	-1,069	-1,194
Net Cash Per Share	-9.94	-8.88	-9.97	-10.82	-11.01	-12.42
Filing Date Shares Outstanding	90.13	92.88	94.93	94.51	95.85	95.03
Total Common Shares Outstanding	90.2	92.88	94.93	94.26	95.82	94.94
Working Capital	383	241.2	313.4	293.3	216.3	171.3
Book Value Per Share	7.07	6.53	8.29	8.59	9.03	7.82
Tangible Book Value	-554	-549.9	-618.7	-708.4	-839.9	-1,062
Tangible Book Value Per Share	-6.14	-5.92	-6.52	-7.52	-8.77	-11.18
Land	-	17.4	20.9	20.6	21.5	23.2
Buildings	-	115.4	130.7	125.3	140.2	145.9
Machinery	-	365.2	442.9	439.5	486.6	480.4
Construction In Progress	-	7.5	5.1	3.8	8.1	8.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.